{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T01:34:03Z","timestamp":1760060043889,"version":"build-2065373602"},"reference-count":35,"publisher":"MDPI AG","issue":"15","license":[{"start":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T00:00:00Z","timestamp":1753920000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Background\/Objectives: Although both the MEL90 (Carl Zeiss Meditec AG, Jena, Germany) and WaveLight EX500 (Alcon Laboratories, Inc., Fort Worth, TX, USA) are two widely used excimer lasers, comparisons between the two remain limited. This study evaluates visual and refractive outcomes from the U.S. Food and Drug Administration (FDA) premarket approval trials of these platforms in the treatment of myopia with and without astigmatism, hyperopia with and without astigmatism, and mixed astigmatism. Methods: Clinical outcomes from FDA premarket approval trials were compared between the recently approved MEL90 and the WaveLight (now termed EX500) excimer lasers. Results: A total of 714 eyes (358 patients) from MEL90 and 1353 eyes (706 patients) from EX500 were analyzed up to 6 months postoperatively. In the hyperopia\/hyperopic astigmatism cohort, the EX500 demonstrated greater efficacy relative to MEL90, with more eyes achieving a postoperative uncorrected distance visual acuity (UDVA) of 20\/20 or better (48.6% vs. 68.7%, respectively; p &lt; 0.001). In both the MEL90 and EX500, at least 85% of eyes with myopia\/myopic astigmatism and 68% with mixed astigmatism achieved a postoperative UDVA of 20\/20 or better. For all refractive cohorts, more than 95% of eyes achieved a UDVA of 20\/40 or better at 6 months (all p &gt; 0.05). The EX500 was more likely to demonstrate an improvement of more than two lines of UDVA compared to baseline CDVA (all p &lt; 0.05). In contrast, the MEL90 showed greater predictability of spherical equivalent within \u00b10.50 D and \u00b11.00 D for the hyperopia\/hyperopic astigmatism cohort (both p = 0.007), as well as within \u00b10.50 D for the myopia\/myopic astigmatism cohort (p &lt; 0.001). Postoperatively, both platforms were associated with decreased glare and halos, although findings were variable in the EX500 mixed astigmatism cohort. Conclusions: Both excimer lasers demonstrated safe and effective outcomes that exceed the threshold set by the FDA.<\/jats:p>","DOI":"10.3390\/jcm14155403","type":"journal-article","created":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T07:49:58Z","timestamp":1754380198000},"page":"5403","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Comparison of Zeiss MEL90 and Alcon WaveLight EX500 Excimer Lasers in FDA Premarket Approval Trials for the Treatment of Myopia, Hyperopia, and Mixed Astigmatism"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-5873-828X","authenticated-orcid":false,"given":"Traeson M.","family":"Brandenburg","sequence":"first","affiliation":[{"name":"Hoopes Vision Research Center, Hoopes Vision, Draper, UT 84020, USA"},{"name":"Creighton University School of Medicine, Omaha, NE 68178, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mina M.","family":"Sitto","sequence":"additional","affiliation":[{"name":"Hoopes Vision Research Center, Hoopes Vision, Draper, UT 84020, USA"},{"name":"Department of Ophthalmology, Wayne State University School of Medicine, Detroit, MI 48201, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2567-8331","authenticated-orcid":false,"given":"Phillip C.","family":"Hoopes","sequence":"additional","affiliation":[{"name":"Hoopes Vision Research Center, Hoopes Vision, Draper, UT 84020, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1024-6250","authenticated-orcid":false,"given":"Majid","family":"Moshirfar","sequence":"additional","affiliation":[{"name":"Hoopes Vision Research Center, Hoopes Vision, Draper, UT 84020, USA"},{"name":"John A. Moran Eye Center, University of Utah School of Medicine, Salt Lake City, UT 84123, USA"},{"name":"Utah Lions Eye Bank, Murray, UT 84107, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,7,31]]},"reference":[{"key":"ref_1","first-page":"849","article-title":"Femtosecond Lasik Versus SMILE for Management of High Myopic Astigmatism: Six Months Outcome","volume":"91","author":"Shehata","year":"2023","journal-title":"Med. J. Cairo Univ."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.joco.2017.08.009","article-title":"Global and regional estimates of prevalence of refractive errors: Systematic review and meta-analysis","volume":"30","author":"Hashemi","year":"2018","journal-title":"J. Curr. Ophthalmol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.ophtha.2016.01.006","article-title":"Global Prevalence of Myopia and High Myopia and Temporal Trends from 2000 through 2050","volume":"123","author":"Holden","year":"2016","journal-title":"Ophthalmology"},{"key":"ref_4","unstructured":"FDA, Center for Devices and Radiological Health (2025, June 19). List of FDA-Approved Lasers for LASIK. FDA. Published Online 3 November 2018, Available online: https:\/\/www.fda.gov\/medical-devices\/lasik\/list-fda-approved-lasers-lasik."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"278","DOI":"10.5455\/aim.2019.27.278-283","article-title":"Excimer Lasers in Refractive Surgery","volume":"27","author":"Pidro","year":"2019","journal-title":"Acta Inform. Medica"},{"key":"ref_6","unstructured":"United States Food and Drug Administration (2025, May 03). Summary of Safety and Effectiveness Data (P060004\/S006), Available online: https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf6\/P060004S006B.pdf."},{"key":"ref_7","unstructured":"United States Food and Drug Administration (2025, May 03). Summary of Safety and Effectiveness Data (P020050), Available online: https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf2\/P020050.pdf."},{"key":"ref_8","unstructured":"United States Food and Drug Administration (2025, May 03). Summary of Safety and Effectiveness Data (P030008), Available online: https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf3\/P030008B.pdf."},{"key":"ref_9","unstructured":"United States Food and Drug Administration (2025, May 03). Summary of Safety and Effectiveness Data (P030008\/S004), Available online: https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf3\/P030008S004B.pdf."},{"key":"ref_10","unstructured":"United States Food and Drug Administration (2025, May 03). Summary of Safety and Effectiveness Data (P020050\/S004), Available online: https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf2\/P020050S004B.pdf."},{"key":"ref_11","unstructured":"United States Food and Drug Administration (2025, May 03). Summary of Safety and Effectiveness Data (P020050\/S012), Available online: https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf2\/p020050s012b.pdf."},{"key":"ref_12","unstructured":"United States Food and Drug Administration (2025, May 03). Summary of Safety and Effectiveness Data (P020050\/S023), Available online: https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf2\/P020050S023B.pdf."},{"key":"ref_13","first-page":"409","article-title":"Visumax Femtosecod and MEL90 Excimer Laser Outcome in Mild, Moderate and High Myopic Astigmatism: Six Months Follow-up","volume":"91","author":"Shehata","year":"2023","journal-title":"Med. J. Cairo Univ."},{"key":"ref_14","first-page":"1","article-title":"Short-term LASIK outcomes for myopia with and without astigmatism using the MEL 90 excimer laser and VisuMax femtosecond laser","volume":"22","author":"Vaswani","year":"2021","journal-title":"Optom Pract."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"9929181","DOI":"10.1155\/2021\/9929181","article-title":"One-Year Visual and Refractive Outcomes following LASIK for Myopia and Myopic Astigmatism with MEL 90 versus Schwind Amaris 750S Excimer Laser: A Comparative Study","volume":"2021","author":"Brar","year":"2021","journal-title":"J Ophthalmol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"316","DOI":"10.3928\/1081597X-20150423-05","article-title":"Outcomes for Myopic LASIK With the MEL 90 Excimer Laser","volume":"31","author":"Reinstein","year":"2015","journal-title":"J. Refract. Surg."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.2147\/OPTH.S455262","article-title":"Retrospective Study Comparing Topography-Guided and Wavefront-Optimized LASIK Procedures in a Single Center","volume":"18","author":"Rowen","year":"2024","journal-title":"Clin. Ophthalmol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"84","DOI":"10.2174\/1874364101812010084","article-title":"Visual Outcomes and Higher Order Aberrations Following LASIK on Eyes with Low Myopia and Astigmatism","volume":"12","author":"Agarwal","year":"2018","journal-title":"Open Ophthalmol. J."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"63","DOI":"10.2174\/1874364101812010063","article-title":"Outcomes of LASIK for Myopia or Myopic Astigmatism Correction with the FS200 Femtosecond Laser and EX500 Excimer Laser Platform","volume":"12","author":"Niparugs","year":"2018","journal-title":"Open Ophthalmol. J."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1016\/j.ophtha.2013.05.010","article-title":"One-Year Outcomes from a Prospective, Randomized, Eye-to-Eye Comparison of Wavefront-Guided and Wavefront-Optimized LASIK in Myopes","volume":"120","author":"Manche","year":"2013","journal-title":"Ophthalmology"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"799","DOI":"10.3928\/1081597X-20181019-01","article-title":"Outcomes for Hyperopic LASIK With the MEL 90\u00ae Excimer Laser","volume":"34","author":"Reinstein","year":"2018","journal-title":"J. Refract. Surg."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/s40123-021-00346-1","article-title":"Comparison of Visual Outcome After Hyperopic LASIK Using a Wavefront-Optimized Platform Versus Other Excimer Lasers in the Past Two Decades","volume":"10","author":"Moshirfar","year":"2021","journal-title":"Ophthalmol. Ther."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"356","DOI":"10.3928\/1081597X-20090617-07","article-title":"Comparing Conventional and Wavefront-optimized LASIK for the Treatment of Hyperopia","volume":"26","author":"Durrie","year":"2010","journal-title":"J. Refract. Surg."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"672","DOI":"10.3928\/1081597X-20180814-01","article-title":"Outcomes for Mixed Cylinder LASIK With the MEL 90\u00ae Excimer Laser","volume":"34","author":"Reinstein","year":"2018","journal-title":"J. Refract. Surg."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1007\/s40123-022-00472-4","article-title":"Refractive Outcomes After LASIK for the Treatment of Mixed Astigmatism with the Allegretto WaveLight EX500","volume":"11","author":"Moshirfar","year":"2022","journal-title":"Ophthalmol. Ther."},{"key":"ref_26","first-page":"S819","article-title":"LASIK for Mixed Astigmatism Using the ALLEGRETTO WAVE: 3- and 6-Month Results with the 200- and 400-Hz Platforms","volume":"26","author":"Stonecipher","year":"2010","journal-title":"J. Refract. Surg."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"81","DOI":"10.3928\/1081-597X-20060101-16","article-title":"Standardized Analyses of Correction of Astigmatism by Laser Systems That Reshape the Cornea","volume":"22","author":"Eydelman","year":"2006","journal-title":"J. Refract. Surg."},{"key":"ref_28","unstructured":"(2012). The Accredited Committee Z80 for Ophthalmic Standards (Standard No. ANSI Z80.11-2012). Available online: https:\/\/webstore.ansi.org\/preview-pages\/VC%20(ASC%20Z80)\/preview_ANSI+Z80.11-2012.pdf?srsltid=AfmBOorrBUkyFJOQ_eEDJRGiQJUBOZRW9eDBJC_hSBN8f-5aW2UqrDvv."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"733","DOI":"10.3928\/1081597X-20221019-01","article-title":"Visual Outcomes of Photorefractive Keratectomy Enhancement After Primary LASIK","volume":"38","author":"Moshirfar","year":"2022","journal-title":"J. Refract. Surg."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1097\/ICU.0000000000000268","article-title":"Comparison of femtosecond and excimer laser platforms available for corneal refractive surgery","volume":"27","author":"Chen","year":"2016","journal-title":"Curr. Opin. Ophthalmol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1007\/s00417-015-3177-x","article-title":"Vector analysis of astigmatism before and after LASIK: A comparison of two different platforms for treatment of high astigmatism","volume":"253","author":"Biscevic","year":"2015","journal-title":"Graefe\u2019s Arch. Clin. Exp. Ophthalmol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"999","DOI":"10.2147\/OPTH.S136061","article-title":"Treatment of moderate-to-high hyperopia with the WaveLight Allegretto 400 and EX500 excimer laser systems","volume":"11","author":"Motwani","year":"2017","journal-title":"Clin. Ophthalmol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.jcrs.2004.01.026","article-title":"Wavefront-optimized ablation profiles: Theoretical background","volume":"30","author":"Mrochen","year":"2004","journal-title":"J. Cataract. Refract. Surg."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"975","DOI":"10.3928\/1081597X-20091016-01","article-title":"Graphic Reporting of Outcomes of Refractive Surgery","volume":"25","author":"Reinstein","year":"2009","journal-title":"J. Refract. Surg."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/S0886-3350(13)80617-7","article-title":"A new method of analyzing vectors for changes in astigmatism","volume":"19","author":"Alpins","year":"1993","journal-title":"J. Cataract. Refract. Surg."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/14\/15\/5403\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:20:08Z","timestamp":1760034008000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/14\/15\/5403"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,31]]},"references-count":35,"journal-issue":{"issue":"15","published-online":{"date-parts":[[2025,8]]}},"alternative-id":["jcm14155403"],"URL":"https:\/\/doi.org\/10.3390\/jcm14155403","relation":{},"ISSN":["2077-0383"],"issn-type":[{"type":"electronic","value":"2077-0383"}],"subject":[],"published":{"date-parts":[[2025,7,31]]}}}